Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification

BACKGROUND: The clinical use of doxorubicin is limited by cardiotoxicity. Histopathologic changes include interstitial myocardial fibrosis and appearance of vacuolated cardiomyocytes. Whereas dysregulation of autophagy in the myocardium has been implicated in a variety of cardiovascular diseases, th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Circulation
Hlavní autoři: Li, Dan L., Wang, Zhao V., Ding, Guanqiao, Tan, Wei, Luo, Xiang, Criollo, Alfredo, Xie, Min, Jiang, Nan, May, Herman, Kyrychenko, Viktoriia, Schneider, Jay W., Gillette, Thomas G., Hill, Joseph A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4856587/
https://ncbi.nlm.nih.gov/pubmed/26984939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.115.017443
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky